Acquired resistance to trastuzumab/pertuzumab or to TâDM1 in vivo can be overcome by HER2 kinase inhibition with TAS0728
Irie, Hiroki, Kawabata, Rumi, Fujioka, Yayoi, Nakagawa, Fumio, Itadani, Hiraku, Nagase, Hideki, Ito, Kimihiro, Uchida, Junji, Ohkubo, Shuichi, Matsuo, KenichiJournal:
Cancer Science
DOI:
10.1111/cas.14407
Date:
April, 2020
File:
PDF, 1.01 MB
2020